Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Cancer Cell
|
November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T Cells
Iñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
Nature Cancer
|
January 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, et al.
Nature Cancer
|
May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, et al.
Cancer Research
|
November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics
Joseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
The Journal of Clinical Investigation
|
December 15, 2015
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A Klebanoff, Christopher D Scott, Anthony J Leonardi, et al.
Cancer Research
|
March 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity
Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy
Richard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Nature
|
March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy
Cristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Cancer Cell
|
November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T Cells
Iñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
Nature Cancer
|
January 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, et al.
Nature Cancer
|
May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, et al.
Cancer Research
|
November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics
Joseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
The Journal of Clinical Investigation
|
December 15, 2015
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A Klebanoff, Christopher D Scott, Anthony J Leonardi, et al.
Cancer Research
|
March 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity
Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy
Richard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Nature
|
March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy
Cristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Page
of 5